Table Graph
      published meta-analysis   sensitivity analysis   studies

angiotensin receptor blockers (ARBs) in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsUniversity of Minnesota, 2021 1.02 [0.02; 52.15] 1.02[0.02; 52.15]University of Minnesota, 202110%117NAnot evaluable deathsdetailed resultsUniversity of Minnesota, 2021 1.02 [0.02; 52.15] 1.02[0.02; 52.15]University of Minnesota, 202110%117NAnot evaluable hospitalizationdetailed resultsUniversity of Minnesota, 2021 3.16 [0.32; 31.34] 3.16[0.32; 31.34]University of Minnesota, 202110%117NAnot evaluable ICU admissiondetailed resultsUniversity of Minnesota, 2021 1.02 [0.06; 16.66] 1.02[0.06; 16.66]University of Minnesota, 202110%117NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-11-01 01:37 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 590,891 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons